Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPennant International Regulatory News (PEN)

Share Price Information for Pennant International (PEN)

Share Price is delayed by 15 minutes
Get Live Data
23.50    0.00 (0.00%)
Bid:
23.00
Ask:
24.00
Spread: 1.00 (4.348%)
Market Cap: £11.19m
PEN Live PriceLast checked at - London Stock Exchange

Intraday Pennant International Share Chart

Major Programme Update

2 May 2019 07:00

RNS Number : 8241X
Pennant International Group PLC
02 May 2019
 

FOR IMMEDIATE RELEASE 02 May 2019

 

 

PENNANT INTERNATIONAL GROUP PLC

 

 

Major Programme Update

 

 

Pennant International Group plc ("Pennant", the "Company" or the "Group"), the AIM quoted supplier of integrated training and support solutions, products and services which train and assist operators and maintainers in the defence and regulated civilian sectors, provides an update on a potential contract award.

 

The Group has been down-selected on a major programme as announced on 9 August 2018. The Group has received notification that the placing of the Pennant contract is now contingent on the prospective customer's single-source 'upstream' contract becoming effective, which may not occur until the second half of 2020.

 

Pennant is engaging with the prospective customer with a view to accelerating the award and, as a result of the relationship established with the prospective customer, is also in discussions on a number of other opportunities.

 

The potential value of the contract to Pennant (£25 million to £30 million) remains unchanged.

 

Having initially received confirmation from the prospective customer that Pennant's contract would be awarded during the latter part of 2018 (with an aggressive timeline for delivery), the Group invested in expanding its operational capacity in order to deliver the contract (and other likely new programmes of work). Accordingly, while the Group is anticipating record revenues for 2019 (in the region of £22 million), costs are presently being incurred which would not otherwise have been (circa £90,000 per month) which is affecting operating margin. The Company will commence a cost-reduction exercise in response to this new timeframe for contract award.

 

The Board does not expect the potential delay in the contract award to have a material impact on market expectations for the current year and, having regard to the Group's pipeline of active opportunities, remains confident about the Company's prospects for the future.

 

 

 

 

Certain information contained in this announcement would have constituted inside information (as defined by Article 7 of Regulation (EU) No 596/2014) ("MAR") prior to its release as part of this announcement and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

 

 

Enquiries:

 

Pennant International Group plc

www.pennantplc.co.uk

Philip Walker, CEO

David Clements, Commercial & Risk Director

+44 (0) 1452 714 914

 

 

WH Ireland Limited

www.whirelandcb.com

Mike Coe

+44 (0) 117 945 3470

 

 

Walbrook PR (Financial PR)

paul.vann@walbrookpr.com

Paul Vann / Tom Cooper

+44 (0)20 7933 8780

+44 (0)7768 807631

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
CNTABMBTMBJMTML
Date   Source Headline
15th Aug 20168:20 amRNSDirector/PDMR Shareholding
15th Aug 20167:00 amRNSPlacing of £3.56m
19th Jul 20167:00 amRNSRecord Order Book drives expansion of premises
15th Jul 20169:30 amRNSHoldings in Company
14th Jul 201610:55 amRNSHolding(s) in Company
14th Jul 20167:00 amRNSDirector Dealing
20th Jun 201612:05 pmRNSGrant of Options
16th Jun 20167:00 amRNSNew Contract Award and Trading Update
1st Jun 20167:14 amRNSNew Contract Awards worth in excess of £13 million
18th May 201612:00 pmRNSDirectorate Change
20th Apr 201611:17 amRNSResult of AGM and GM
19th Apr 20167:00 amRNSDirectorate Change
23rd Mar 20167:00 amRNSDocuments available on the Company's website
7th Mar 20167:00 amRNS2015 Final Results
3rd Mar 201611:00 amRNSDirectorate Change
5th Feb 20167:00 amRNSNew Contract Award & Notice of 2015 Final Results
11th Dec 20157:00 amRNSTrading Update
17th Nov 20157:00 amRNSDirectorate Change
19th Oct 20151:40 pmRNSDirector/PDMR Shareholding
5th Oct 20157:00 amRNSDirector Incentivisation
28th Sep 20157:00 amRNSNew £7million Contract Award
28th Sep 20157:00 amRNS2015 Interim Results
18th Sep 201512:00 pmRNSNotice of Results
26th Aug 20152:47 pmRNSHolding(s) in Company
14th Apr 201511:12 amRNSResult of AGM and GM
8th Apr 20152:30 pmRNSDirector/PDMR Shareholding
17th Mar 201512:00 pmRNSDocuments available on the Company's website
17th Mar 20159:55 amRNSDocuments available on the Company's website
17th Mar 20157:00 amRNS2014 Final Results
6th Mar 20157:00 amRNSNotice of Final Results
22nd Jan 20157:00 amRNSPre-close Trading Update
10th Nov 201412:00 pmRNSTransaction in Own Shares
22nd Sep 20147:00 amRNSDirectorate Change
17th Sep 20147:00 amRNSContract win
8th Sep 20147:00 amRNSHalf Yearly Report
1st Sep 201411:35 amRNSNotice of Results
15th Jul 20144:29 pmRNSDirector/PDMR Shareholding
24th Jun 20144:36 pmRNSDirector Dealing
6th Jun 20145:17 pmRNSDirector/PDMR Shareholding
29th Apr 20144:20 pmRNSDirector Incentivisation
10th Apr 20143:39 pmRNSResult of Meeting
12th Mar 20147:00 amRNSDirectorate Change
10th Mar 20147:00 amRNSFinal Results
10th Feb 20143:45 pmRNSHolding(s) in Company
3rd Feb 20142:14 pmRNSHolding(s) in Company
3rd Feb 20142:00 pmRNSHolding(s) in Company
9th Dec 20134:15 pmRNSHolding(s) in Company
14th Nov 201311:10 amRNSNotification of Major Interest of Shares
21st Oct 201311:03 amRNSDirector/PDMR Shareholding
5th Aug 20137:00 amRNSHalf Yearly Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.